Amgen's Lumakras became the first FDA-approved drug that addresses the elusive KRAS mutation, but Mirati believes its newly approved therapy, Krazati, could be better. The small molecule's features include the ability to penetrate into the brain, where it can address cancer that has spread to the central nervous system.
At the 5th annual HLTH conference in Las Vegas, healthcare executives from companies including Dan Vahdat of Huma, responded to questions such as what's the difference between a positive and negative user experience in telehealth? They also previewed their plans for 2023.
By Frank Vinluan Tuesday, December 13, 2022 8:00 PM
Nearly all patients treated with the Novartis drug iptacopan achieved the hemoglobin goals of pivotal study compared to zero patients who received the AstraZeneca drugs that are the standard of care in a rare blood disorder. The results were presented Tuesday during the annual meeting of the American Society of Hematology.
The majority of health systems now offer some sort of home-based care program, according to a new survey of hospital leaders. The biggest goals of these programs are to improve patient outcomes through reductions in readmissions, hospitalizations and emergency room visits, the report found.
By Marissa Plescia Tuesday, December 13, 2022 6:07 PM
CMS hopes the changes will increase healthcare access for underserved populations, streamline the plan selection process and simplify enrolling in Marketplace coverage.
This summer, Adventist Health began a three-year partnership with Emcara Health, a primary care provider group that deploys community health workers into the places people live. Five months later, Emcara is saying that the program is seeing significant engagement and improving patients' ability to keep up with their care plan.
By Marissa Plescia Tuesday, December 13, 2022 3:41 PM
About 62% of Americans don't trust their health plan when it comes to finding care, a Ribbon Health survey found. Providing more accurate information on provider directories could repair this trust.
Remaining at or near the top of employers' and consumers' choices when it comes to health coverage will require insurers to make large investments in infrastructure, processes and people to overcome the status quo.
By Hooman Abediasl Tuesday, December 13, 2022 9:10 AM
One technology that has tremendous potential to both broaden and improve access to preventive healthcare is wearable biosensing — more specifically, the continuous, non-invasive monitoring of multiple biomarkers from a smartwatch or wristband.
Among the takeaways from HLTH 2022 were the impact of consolidation on clinicians, behavioral health tools to help consumers manage stress and anxiety more productively, and how health tech and medtech companies are supporting remote patient monitoring and testing.
MedCity News 611 Broadway New York, NY 10012 United States
You received this email because you are subscribed to MedCity Daily Digest from MedCity News.
Update your email preferences to choose the types of emails you receive.
No comments